Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.

Murillo D, Domínguez-Jurado E, Huergo C, Gallego B, Díez P, Ferreras A, Álvarez-González E, Rey V, Rodríguez-Santamaría M, Indurain AS, de Andrés Segura F, Bravo I, Ríos Á, Fernández-Velasco AA, Fernández-Vega I, Alonso-Moreno C, Rodríguez R.

Open source

DOI: 10.1080/10717544.2026.2671485
Published: 2026-05-11
Container: Drug Deliv
Publisher: Taylor & Francis
Open access: yes

Credibility signals

uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/10717544.2026.2671485,
  title = {Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.},
  author = {Murillo D and  Domínguez-Jurado E and  Huergo C and  Gallego B and  Díez P and  Ferreras A and  Álvarez-González E and  Rey V and  Rodríguez-Santamaría M and  Indurain AS and  de Andrés Segura F and  Bravo I and  Ríos Á and  Fernández-Velasco AA and  Fernández-Vega I and  Alonso-Moreno C and  Rodríguez R.},
  year = {2026},
  journal = {Drug Deliv},
  doi = {10.1080/10717544.2026.2671485},
  url = {https://doi.org/10.1080/10717544.2026.2671485}
}

RIS

TY  - JOUR
TI  - Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.
AU  - Murillo D
AU  -  Domínguez-Jurado E
AU  -  Huergo C
AU  -  Gallego B
AU  -  Díez P
AU  -  Ferreras A
AU  -  Álvarez-González E
AU  -  Rey V
AU  -  Rodríguez-Santamaría M
AU  -  Indurain AS
AU  -  de Andrés Segura F
AU  -  Bravo I
AU  -  Ríos Á
AU  -  Fernández-Velasco AA
AU  -  Fernández-Vega I
AU  -  Alonso-Moreno C
AU  -  Rodríguez R.
PY  - 2026
JO  - Drug Deliv
DO  - 10.1080/10717544.2026.2671485
UR  - https://doi.org/10.1080/10717544.2026.2671485
ER  -

APA

D, M., E, D., C, H., B, G., P, D., A, F., E, Á., V, R., M, R., AS, I., F, D. A. S., I, B., Á, R., AA, F., I, F., C, A., & R., R. (2026). Liposome-mediated delivery of a ruthenium-based metallodrug to overcome cisplatin resistance in osteosarcoma.. Drug Deliv. https://doi.org/10.1080/10717544.2026.2671485

Source records

europe-pmc · retrieved 2026-09-25T17:29:05.661Z
datacite · retrieved 2026-09-25T17:29:05.641Z
datacite · retrieved 2026-09-25T17:29:05.641Z
doaj · retrieved 2026-09-25T17:29:05.661Z